Fox SH - Search Results

1

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.

Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M. Voon V, et al. Among authors: fox sh. Arch Neurol. 2007 Feb;64(2):212-6. doi: 10.1001/archneur.64.2.212. Arch Neurol. 2007. PMID: 17296836

2

Pure cerebello-olivary degeneration of Marie, Foix, and Alajouanine presenting with progressive cerebellar ataxia, cognitive decline, and chorea.

Fox SH, Nieves A, Bergeron C, Lang AE. Fox SH, et al. Mov Disord. 2003 Dec;18(12):1550-4. doi: 10.1002/mds.10606. Mov Disord. 2003. PMID: 14673899

3

A writing device improves writing in primary writing tremor.

Espay AJ, Hung SW, Sanger TD, Moro E, Fox SH, Lang AE. Espay AJ, et al. Among authors: fox sh. Neurology. 2005 May 10;64(9):1648-50. doi: 10.1212/01.WNL.0000160390.25028.C3. Neurology. 2005. PMID: 15883338 Clinical Trial.

4

Prospective prevalence of pathologic gambling and medication association in Parkinson disease.

Voon V, Hassan K, Zurowski M, Duff-Canning S, de Souza M, Fox S, Lang AE, Miyasaki J. Voon V, et al. Neurology. 2006 Jun 13;66(11):1750-2. doi: 10.1212/01.wnl.0000218206.20920.4d. Neurology. 2006. PMID: 16769956 Clinical Trial.

5

Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure.

Fox SH, Lang AE, Brotchie JM. Fox SH, et al. Mov Disord. 2006 Oct;21(10):1578-94. doi: 10.1002/mds.20936. Mov Disord. 2006. PMID: 16874752 Review.

6

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.

Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J. Voon V, et al. Neurology. 2006 Oct 10;67(7):1254-7. doi: 10.1212/01.wnl.0000238503.20816.13. Epub 2006 Sep 6. Neurology. 2006. PMID: 16957130 Clinical Trial.

7

Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease.

Visanji NP, Gomez-Ramirez J, Johnston TH, Pires D, Voon V, Brotchie JM, Fox SH. Visanji NP, et al. Among authors: fox sh. Mov Disord. 2006 Nov;21(11):1879-91. doi: 10.1002/mds.21073. Mov Disord. 2006. PMID: 16960862

8

Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease.

Fox SH, Visanji NP, Johnston TH, Gomez-Ramirez J, Voon V, Brotchie JM. Fox SH, et al. Arch Neurol. 2006 Sep;63(9):1343-4. doi: 10.1001/archneur.63.9.1343. Arch Neurol. 2006. PMID: 16966523 No abstract available.

9

Antidepressants and psychosis in Parkinson disease: a case series.

Voon V, Fox S, Butler TR, Lang AE. Voon V, et al. Int J Geriatr Psychiatry. 2007 Jun;22(6):601-4. doi: 10.1002/gps.1764. Int J Geriatr Psychiatry. 2007. PMID: 17450623 No abstract available.

10

Medication-related impulse control and repetitive behaviors in Parkinson disease.

Voon V, Fox SH. Voon V, et al. Among authors: fox sh. Arch Neurol. 2007 Aug;64(8):1089-96. doi: 10.1001/archneur.64.8.1089. Arch Neurol. 2007. PMID: 17698698 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters